A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses2018-01-17T17:04:40-05:00
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis2018-01-17T17:01:01-05:00
